Fragile X expression and X inactivation

✍ Scribed by Doris Wöhrle; Peter Steinbach

• Publisher: Springer
• Year: 1991
• Tongue: English
• Weight: 504 KB
• Volume: 87
• Category: Article
• ISSN: 0340-6717
• DOI: 10.1007/bf00197160

✦ Synopsis

The major concept of fragile X pathogenesis postulates that the fragile site at band Xq27.3 [Ira(X)] represents the primary defect. The expression of Ira(X) is predicted to be an intrinsic property of the mutated chromosome and, hence, should not be suppressed by X inactivation in females or induced by X-linked trans-acting factors. We made fibroblast clones of a fra(X)-positire female. Monoclonality was demonstrated using the DNA methylation assay at DXS255. The mutated X chromosomes and their states of genetic activity in the different clones were also defined by molecular methods. Five clones were selected to induce expression of Ira(X) by 10 -7 M FUdR; two carried an active mutated X chromosome, in the other three the mutated X chromosome was inactivated. Fra(X) was found expressed in both types of clones. The percentages of positive cells were as high as 7-10%, regardless of the genetic activity of the mutated X chromosomes. DNA replicating patterns, obtained by BUdR labelling, demonstrated that expression occurred only on the mutated X chromosomes previously identified by molecular methods. The concept that the fragile site represents the primary mutation is now strongly supported by experimental evidence. The expression of Ira (X) in females is independent of X inactivation and other trans-acting factors.